GE Aerospace is significantly overvalued, with a trailing P/E ratio of 40x and stretched fundamental comparisons vs. peers.

Analyst Joanne Wuensch of Citi reiterated a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report), retaining the price target ...

GE Vernova currently plans to make the new DLN system available for new and existing B- and E- gas turbines as early as 2026.

General Electric Co. and investors’ $362.5 million settlement of securities fraud claims over an operating cash shortfall in ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Fund” fourth quarter 2024 investor letter. A copy of the ...

GE Vernova shares jumped Tuesday as Bank of America analysts raised their price target ahead of the company’s fourth-quarter ...

GE Aerospace shares are trading higher by 1.6% during Tuesday's session. Shares are rising following the release of ...

BofA raised the firm’s price target on GE Vernova (GEV) to $415 from $380 and keeps a Buy rating on the shares. The firm believes turbine ...

GE HealthCare is deploying AI across its entire ecosystem - from improving medical devices to ... [+] transforming clinical workflows and boosting hospital efficiency. The global healthcare system ...